The REMEDY project aims to transform architectural materials through the development of a novel technology: the archibiome tattoo. This innovation utilizes engineered microbial consortia embedded in living inks to create responsive, resilient, and aesthetically customizable surfaces for new and existing buildings. As the project advances interdisciplinary research across microbiology, additive manufacturing, materials science, and architecture, it generates diverse and complex datasets that require careful and structured management. The Data Management Plan (DMP) for the REMEDY project is designed to support the project’s ambitious goals by fostering rigorous data stewardship, promoting transparency and reproducibility, and enabling future innovation in the emerging field of engineered living materials in architecture.
Anna Sandak (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: